Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Committee for Medicinal Products for Human Use (CHMP)
The Committee is responsible for preparing the European Medicines Agency's (EMA) opinions on all questions concerning medicinal products for human use, in accordance with Regulation (EC) No 726/2004.
See also:
Committee for Medicinal Products for Human Use (CHMP)
Related terms
Informed consent, European Medicines Agency, Drug usage/utilisation review (DUR), Blind (clinical trial terms), ABPI Code of Practice, Controlled trial, Trial endpoint, Experimental drug, Risk-benefit analysis, Dose-ranging trial, Pharmaceutical Pricing Regulation Scheme (PPRS), Arm, Toxicity, Endpoint, Economic regulation,
Featured jobs
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Manager
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Publications director
-
Competitive salary and bonus scheme
-
Account Director
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Manager (PR)
-
Great Benefits
- Account Director, Healthcare Communications
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- Immutep spikes on trial of its LAG-3 drug with Keytruda
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- As new coronavirus outbreaks emerge, fears of a global pandemic escalate
- Coronavirus outbreak escalation could impact drug supply chain
- FDA accepts review to broaden GSK’s Zejula label
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Menlo slumps as itching drug fails mid-stage trial
- Trial of Amgen, Servier’s heart failure drug clears interim check
- Policy and public health: all the decisions we can't see
- Genentech pays $30m upfront to access Bicycle Therapeutic's discovery technology
- The ALS patient journey
PMHub
Frontera Group
Welcome to Frontera Group, where our agencies immerse you in the world of the patient...
Quick links
Infographics
